Dr Fong is a Medical Oncologist specialising in Gynaecological cancer, Prostate cancer and research into oncology Phase I trials.

Peter is a first class honours graduate of the University of Queensland Medical School in Australia graduating in 1994. He trained in Australia and New Zealand hospitals, gaining his specialist qualifications in 2003 and working as a consultant. Between 2004 and 2008, he undertook a clinical research fellowship at the Royal Marsden Hospital in London in Phase I Oncology Drug Development, being an investigator in many trials. During this time he also worked in gynaecology and the prostate cancer drug unit. He spent 2 years in the laboratory doing post-graduate translational research on targeted agents at the Institute of Cancer Research, University of London.

Peter resumed work as a medical oncologist at Auckland Hospital in 2008. He is in the Gynaecological Cancer team, working in a multi-disciplinary structure. He is also in the Genitourinary Cancer team, with a particular focus on Prostate Cancer, having started the medical oncology prostate practice. He is on the Research Advisory Committee of the Australia and New Zealand Gynaecological Oncology Group (ANZGOG) and the Prostate Scientific Committee of the Australia and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).

Peter is actively involved in the NZ Gynaecological and Genitourinary Cancer Special Interest Group. He is an Honorary Academic at the Pharmacology Department, University of Auckland, continuing his interest in new cancer drugs and cancer biology. He collaborates with researchers at the University of Auckland on various projects. He is a principal investigator in numerous clinical trials (especially Gynaecological and Prostate) from Phase I to III. He has been published in major peer-reviewed journals.

Whilst Peter focuses on evidence based practice and discusses novel therapeutics, he tailors his discussion with patients according to their needs.

Prostate cancer, Gynaecological cancer, Oncology trials and Drug Development

MB BS 1994 Queensland; FRACP 2003

Prostate Cancer

Gynaecological Cancer

Phase I trials/Drug Development/Translational Research

Genitourinary Cancer

Medical Oncologist, Consultant Medical Oncologist

Royal Marsden Hospital/The Institute of Cancer Research, London, United Kingdom

16 July 1997

Internal Medicine